- Oral presentation
- Open Access
Childhood glycaemic control has an enduring effect on the lifetime risk of microvascular complications in type 1 diabetes mellitus
© White et al; licensee BioMed Central Ltd. 2015
- Published: 28 April 2015
- Glycaemic Control
- Severe Complication
- Microvascular Complication
- Poor Group
- Optimal Group
The development of diabetes-related microvascular complications in type 1 diabetes (T1DM) is known to be related to glycaemic control, but the degree to which variations in HbA1c across the lifetime contributes to this risk is unknown. Our hypothesis was that individuals with poor control in childhood and subsequent improved control in adulthood would still have an increased risk of severe diabetes-related complications when compared with individuals who achieved good control throughout the lifecourse. This study aimed to investigate this premise in a cohort for whom serial lifetime glycaemic data are available. The study population comprised children diagnosed with T1DM <18 years at The Royal Children’s Hospital (Melbourne) who transitioned to the Royal Melbourne Hospital for ongoing (adulthood) care. Data were collected through BioGrid Australia, a biorepository allowing inter-institutional data linkage, and included demographics as well as serial HbA1c and complication data. ‘Severe complications’ were defined as severe diabetes-related eye disease, renal failure, ulceration/amputation or death. Glycaemic control was categorised according to HbA1c changes over time, based on median values throughout the lifecourse; “Optimal” (≤8.2% throughout lifecourse), “Improving” (>8.2% in childhood, ≤8.2% in adulthood), “Worsening” (≤8.2% in childhood, >8.2% in adulthood), “Poor” (>8.2% throughout lifecourse). A total of 503 (male=253) individuals were identified, diagnosed 1975-2010. At the time of follow up, mean (SD) age was 27.9 (6.2) years and median (IQR) duration of diabetes was 17.8 (12.2, 23.2) years. Severe complications were documented in 26 (5.2%) and were associated with mean HbA1c at age 16-30 years (<0.05) and intra-individual lifetime glycaemic variability expressed as HbA1cSD (p=0.02). The relative risk (95% confidence interval) of developing severe complications in the improving, worsening and poor groups was 14.9 (1.7-130.9, p=0.01, n=50), 12.5 (1.4-109.4, p <0.01, n=60) and 15.4 (2.1-114.8, p <0.01, n=206) respectively when compared to the optimal group (n=187). In conclusion, the overall rate of severe complications is low in this cohort despite the lifecourse poor glycaemic control demonstrated in 40.1%. Our findings demonstrate that poor glycaemic control in childhood has a lasting effect on the development of severe microvascular complications in adulthood.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.